Abstract
Introduction: Mexico was the first country to initiate massive vaccination with heptavalent pneumococcal conjugate vaccine (PCV-7) in children. There is no information regarding pneumococcal invasive disease (PID) in children before and after implementation of PCV-7 in Mexico or elsewhere in Latin America. Methodology: During October 2005 to September 2010, active surveillance for pediatric PID was initiated at Tijuana General Hospital. Only culture-confirmed cases from sterile fluids were included in the study. Serotype identification was also performed. Results: Twenty-eight pediatric PID cases were confirmed. Streptococcus pneumoniae was the main cause of pleural empyema (n = 13). It was also the second most common cause of confirmed bacterial meningitis (n = 10), followed by Neisseria meningitidis(n=?), and the only cause of otomastoiditis with bacterial isolation (n = 5). Vaccine-associated serotypes decreased from 54% before PCV-7 introduction to the vaccination schedule, to only 5.6% after PCV-7 implementation. Serotypes 19A and 7F (47% and 33% respectively) were predominant following PCV-7 vaccination. Conclusions: Serotype substitution in PID is present in the northern border of Mexico following PCV-7 vaccination in children. © 2012 Chacon-Cruz et al.
Author supplied keywords
Cite
CITATION STYLE
Chacon-Cruz, E., Velazco-Mendez, Y., Navarro-Alvarez, S., Rivas-Landeros, R. M., Volker, M. L., & Lopez-Espinoza, G. (2012). Pneumococcal disease: Emergence of serotypes 19A and 7F following conjugate pneumococcal vaccination in a Mexican hospital. Journal of Infection in Developing Countries, 6(6), 516–520. https://doi.org/10.3855/jidc.1954
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.